Back to UBS Group AG UBS Group AG

KAPAKAPA
6 quarters

Position history for UBS Group AGUBS Group AG's holdings in KAIROS PHARMA LTD

UBS Group AG holds 6,261 shares of KAPA (KAIROS PHARMA LTD), worth $2,404 as of 2026-Q2. This is a new position.

Current Value

$2,404

Current Shares

6,261

Total Value Change

-$14,080

Total Shares Change

-4,584

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
6,261
-
$2,4040.0%$0.38
19
2025-Q4
Exited
0
-100.0%
$00.0%$0.70
0
2025-Q3
Decreased
5,979
-36.8%
$6,9950.0%$1.12
0
2025-Q2
Increased
9,458
+238.8%
$6,7060.0%$0.67
18
2025-Q1
Decreased
2,792
-74.3%
$2,6130.0%$0.92
0
2024-Q4
New
10,845
-
$16,4840.0%$1.56
28

Other major holders of KAPA: CITADEL ADVISORS LLC, VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used